Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Will Lawn |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Adjunctive ketamine with relapse prevention based psychological therapy in the treatment of alcohol use disorder / Meryem Grabski en The American Journal of Psychiatry, Año 2022 Vol. 179 - No. 2 (Febrero)
[artículo]
Título : Adjunctive ketamine with relapse prevention based psychological therapy in the treatment of alcohol use disorder Tipo de documento: texto impreso Autores: Meryem Grabski, Autor ; Amy McAndrew, Autor ; Will Lawn, Autor Fecha de publicación: 2022 Artículo en la página: pp. 152-162 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos adictivos y relacionados con sustancias, Alcohol, Ketamina/Esketamina, Psicoterapia Resumen: Early evidence suggests that ketamine may be an effective treatment to sustain abstinence from alcohol. The authors investigated the safety and efficacy of ketamine compared with placebo in increasing abstinence in patients with alcohol use disorder. An additional aim was to pilot ketamine combined with mindfulness-based relapse prevention therapy compared with ketamine and alcohol education as a therapy control. Link: ./index.php?lvl=notice_display&id=28334
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 152-162[artículo] Adjunctive ketamine with relapse prevention based psychological therapy in the treatment of alcohol use disorder [texto impreso] / Meryem Grabski, Autor ; Amy McAndrew, Autor ; Will Lawn, Autor . - 2022 . - pp. 152-162.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2022 Vol. 179 - No. 2 (Febrero) . - pp. 152-162
Palabras clave: Trastornos adictivos y relacionados con sustancias, Alcohol, Ketamina/Esketamina, Psicoterapia Resumen: Early evidence suggests that ketamine may be an effective treatment to sustain abstinence from alcohol. The authors investigated the safety and efficacy of ketamine compared with placebo in increasing abstinence in patients with alcohol use disorder. An additional aim was to pilot ketamine combined with mindfulness-based relapse prevention therapy compared with ketamine and alcohol education as a therapy control. Link: ./index.php?lvl=notice_display&id=28334